Investigators: Alex Gamma, PhD, Edi Frei, Dietrich Lehmann (1), Roberto D. Pascual-Marqui (1), Daniel Hell and Franz Vollenweider, MD Research Unit and (1) The KEY Institute for Brain-Mind Research, University …
A pilot study of MDMA therapy in the treatment of PTSD has been approved and will be the first formal therapy study with MDMA ever conducted. (Read current update) MAPS has pledged $54,000 for this study; …
Investigator: Jordi Cam, MD, Magi Farr, MD, et al. Institut Municipal d’Investigacio Medica – Barcelona, Spain Contact: Jordi Camí, MD or Magi Farré, MD Sponsor: Funded in part by …
Investigators: Charles S. Grob, MD, and Russell E. Poland, PhD Harbor-UCLA Medical Center – Torrance, California, USA Sponsor: MAPS, Harbor/UCLA Contact: , FDA-approved Phase 1 dose-response safety …
(doctoral dissertation) Investigator: Roger Marsden California Institute of Integral Studies, Clinical Psychology Contact: Sponsors: 1998 Kranzke Scholarship; MAPS What are the different frameworks being …
Investigator: John Henry, MD University College London, England Contact: This was a neurotoxicity study. Henry is directing additional MDMA studies at this time. Fallon JK, Kicman AT, Henry JA, Milligan …
Investigators: Marianne Bloch, MD, Jurai Styk, MD and Dr. Samuel Widmer, MD Sponsor: Swiss Medical Society for Psycholytic Therapy From 1988 to 1993 therapists with the Swiss Medical Society for Psycholytic …
Investigators: Alex Gamma, PhD, Franz Vollenweider, MD Psychiatric University Hospital – Zrich, Switzerland Sponsor: UBS Science Foundation and others Contact: Franz Vollenweider, MD, Alex Gamma …
Investigator: Rick Doblin, Ph.D. This study, originally published in the Journal of Psychoactive Drugs [Oct-Dec 1998] is one in a series of long-term follow-ups to early psychedelic research that MAPS …
Investigators: Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy- Byrne PP Department of Psychiatry, Harborview Medical Center, University of Washington, Seattle Ketamine or saline was administered …
August 30 - September 1, 1999. MAPS Conference on the Clinical Utility of MDMA and MDE (Dead Sea Conference). George Greer, MD. 56K: Clip 1 / Clip 2 28K: Clip 1 / Clip 2 Charles Grob, MD. 56K: Clip 1 / …
On September 1, 1999, Jordi Camí, MD, PhD, Magi Farré, MD, PhD, and José Carlos Bouso, PhD presented their Phase 1 clinical study of MDMA-assisted psychotherapy for PTSD at the MAPS MDMA …